Description
Levopa 110 mg is a combination medication containing Levodopa and Carbidopa, manufactured by ACME Laboratories Ltd. It is primarily used to treat Parkinson's disease and related disorders, such as post-encephalitic parkinsonism and symptomatic parkinsonism following carbon monoxide or manganese intoxication. Levodopa serves as a precursor to dopamine, crossing the blood-brain barrier and converting into dopamine in the brain, thereby alleviating symptoms like rigidity and bradykinesia. Carbidopa inhibits the peripheral decarboxylation of levodopa, ensuring more levodopa reaches the brain and reducing side effects like nausea.
.png)
.png)
.jpeg)
.webp)
.jpeg)
.webp)
.webp)
.png)
.jpeg)
Change Language